US › Healthcare

ADARx Pharmaceuticals, Inc. Common Stock (ADRX)

US · Healthcare · Biotechnology

$17.65-0.28%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$746,000

Net profit

$-25.8M

Net margin

-3,452.9%

Key statistics

Market cap

$1.89B

Forward P/E

0.0

P/B

0.00

Book value

$-22.16

EPS (TTM)

$-1.16

52-week high

$23.21

52-week low

$16.64

50-day MA

$18.76

200-day MA

$18.76

Shareholding

Insiders

41.78%

Institutions

29.57%

Recent filings & reports

Document	Date
Charter / bylaws change · Q3 2026 HEADLINE NUMBERS • ADARx Pharmaceuticals closed its IPO on September 28, 2026, selling 26,250,000 shares at $17.00 per share. • IPO gross proceeds w	2026-09-28

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for ADARx Pharmaceuticals, Inc. Common Stock — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.